Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; Gland Pharma informed that the ESOP Compensation Committee of the Board of Directors of the Company has allotted 311,800 Equity shares of Re 1 each of the Company, fully paid up, on May 5, 2021 to employees on exercise of their Stock Options (ESOP) pursuant to the company’s Employee Stock Options Scheme, 2019. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs 163,904,723 comprising of 163,904,723 Equity shares of face value Re 1 each.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1674.60 |
| Dr. Reddys Lab | 1291.00 |
| Cipla | 1304.90 |
| Zydus Lifesciences | 947.50 |
| Lupin | 2357.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: